Cleared Traditional

K051471 - CARDIODAY

K051471 is an FDA 510(k) clearance for CARDIODAY, manufactured by Getemed Medizin- Und Informationstechnik AG. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 26-day FDA review.

K051471 · Getemed Medizin- Und Informationstechnik AG · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2005
Decision
26d
Days
Class 2
Risk

K051471 is an FDA 510(k) clearance for the CARDIODAY. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Getemed Medizin- Und Informationstechnik AG (Great Neck, US). The FDA issued a Cleared decision on June 29, 2005 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Getemed Medizin- Und Informationstechnik AG devices

FDA 510(k) Submission Details - K051471

510(k) Number K051471 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 03, 2005
Decision Date June 29, 2005
Days to Decision 26 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
99d faster than avg
Panel avg: 125d · This submission: 26d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 285
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K051471.
DATEX-OHMEDA S/5 CARDIAC OUTPUT AND SVO2 MODULE, E-COPSV AND ACCESSORIES
K052977 · Ge Healthcare · Nov 2005
CARTO RMT EP NAVIGATION SYSTEM
K042681 · Biosense Webster, Inc. · Sep 2005
MARS HOLTER ANALYSIS WORKSTATION
K051026 · Ge Medical Systems Information Technologies · Jul 2005
MAC-LAB/CARDIOLAB EP/COMBOLAB SYSTEM
K050093 · Ge Medical Systems Information Technologies · May 2005
MUSE CARDIOLOGY INFORMATION SYSTEM
K050614 · Ge Medical Systems Information Technologies · Apr 2005
CARTO XP EP NAVIGATION SYSTEM, SOFTWARE VERISON 8
K042999 · Biosense Webster, Inc. · Mar 2005